Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis.

CONCLUSION: Sofosbuvir plus velpatasvir therapeutic regimen was highly effective in HCV patients without advanced liver disease naïve to previous DAA regimen independently the different HCV genotypes.
PMID: 31124995 [PubMed - in process]

Source: Acta Bio-Medica : Atenei Parmensis - May 22, 2019 Category: General Medicine Authors: Pisaturo M, Russo A, Onorato L, Coppola N Tags: Acta Biomed Source Type: research